tiprankstipranks
pc:eleph

Elephas Biosciences Corporation

Elephas Biosciences Corporation has developed an innovative live tumor profiling platform for immunotherapy response prediction. The platform enables real-time characterization of immune response by preserving the native tumor microenvironment from a live core needle biopsy and addressing tumor heterogeneity.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$40M
Total Amount Raised$40M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$40M
Latest Funding Amount$40M
Latest Funding RoundSeries B
Latest Funding RoundSeries B
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Nov 06, 2025
Series B
$40.00M

Related News and Analysis